Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2

Retrieved on: 2025-01-26 11:07:35

Tags for this article:

Click the tags to see associated articles and topics

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2. View article details on hiswai:

Excerpt

... hydroxychloroquine (HCQ) induced on-target senescence at lower palbociclib doses. We conducted a phase I trial (NCT03774472 registered in ...

Article found on: www.nature.com